S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CAPR Capricor Therapeutics Inc

19.35

-0.75 (-3.73%)

02 Nov 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Capricor Therapeutics (NASDAQ:CAPR)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Capricor Therapeutics Charts.

Capricor Therapeutics (NASDAQ:CAPR)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Capricor Therapeutics Charts.

Capricor Therapeutics Inc News

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 25 October 2024 (1 week ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 23 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Saturday 19 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 18 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 17 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock
Thursday 17 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Thursday 17 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 17 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 17 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Capricor Therapeutics Announces Proposed Public Offering of Common Stock
Thursday 17 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Thursday 17 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress
Saturday 12 October 2024 (3 weeks ago) • GlobeNewswire Inc.

More Capricor Therapeutics Inc News Articles

Wrapped DogeCoin

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions